Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Jackie Han"'
Autor:
Wolfgang Koenig, Kausik K. Ray, Ulf Landmesser, Lawrence A. Leiter, Gregory G. Schwartz, R. Scott Wright, Lorena Garcia Conde, Jackie Han, Frederick J. Raal
Publikováno v:
American Journal of Preventive Cardiology, Vol 14, Iss , Pp 100503- (2023)
Patients with cerebrovascular disease (CeVD) have been shown to benefit from lipid-lowering therapies, but guideline-recommended levels of low-density lipoprotein cholesterol (LDL-C) are often not attained with statin treatment alone. The ORION-9, OR
Externí odkaz:
https://doaj.org/article/17972f0d39ca43feb599af064db33e6b
Autor:
Jun Guo, Jie Jin, Mototsugu Oya, Hirotsugu Uemura, Shunji Takahashi, Katsunori Tatsugami, Sun Young Rha, Jae-Lyun Lee, Jinsoo Chung, Ho Yeong Lim, Hsi Chin Wu, Yen Hwa Chang, Arun Azad, Ian D. Davis, Marlene J. Carrasco-Alfonso, Bhupinder Nanua, Jackie Han, Qasim Ahmad, Robert Motzer
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-10 (2018)
Abstract Background The international, phase 3 COMPARZ study demonstrated that pazopanib and sunitinib have comparable efficacy as first-line therapy in patients with advanced renal cell carcinoma, but that safety and quality-of-life profiles favor p
Externí odkaz:
https://doaj.org/article/33806d909a3a413a8fa582382894db97
Autor:
Zhen Qi, Yehua Li, Bing Zhao, Chi Xu, Yuan Liu, Haonan Li, Bingjie Zhang, Xinquan Wang, Xiao Yang, Wei Xie, Baojie Li, Jing-Dong Jackie Han, Ye-Guang Chen
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-14 (2017)
Bone morphogenetic protein (BMP) maintains intestinal homeostasis by restricting its hyperproliferation but whether it directly regulates the stem cells is unknown. Here the authors show that BMP constrains the Lgr5+stem cell expansion under both hom
Externí odkaz:
https://doaj.org/article/1cfafbf39370423c97491755711f11d9
Autor:
Claudia Sommerer, Christophe Legendre, Franco Citterio, Yoshihiko Watarai, Rainer Oberbauer, Nikolina Basic-Jukic, Jackie Han, Apurva Gawai, Peter Bernhardt, Steve Chadban
Publikováno v:
Transplantation.
Publikováno v:
In The Lancet Regional Health - Western Pacific August 2023 37
Autor:
Wolfgang Koenig, Lorena Garcia Conde, Ulf Landmesser, Lawrence A. Leiter, Kausik K. Ray, Gregory G. Schwartz, R Scott Wright, Jackie Han, Frederick J. Raal
Publikováno v:
Cardiovascular Drugs and Therapy.
Purpose Patients with polyvascular disease (PVD) are at very high cardiovascular risk and require intensive lipid-lowering therapy. This analysis describes the lipid-lowering efficacy and safety of inclisiran versus placebo in patients with and witho
Autor:
Lyad Zamir, Reena Singh, Elisha Nathan, Ralph Patrick, Oren Yifa, Yfat Yahalom-Ronen, Alaa A Arraf, Thomas M Schultheiss, Shengbao Suo, Jing-Dong Jackie Han, Guangdun Peng, Naihe Jing, Yuliang Wang, Nathan Palpant, Patrick PL Tam, Richard P Harvey, Eldad Tzahor
Publikováno v:
eLife, Vol 6 (2017)
Novel regenerative therapies may stem from deeper understanding of the mechanisms governing cardiovascular lineage diversification. Using enhancer mapping and live imaging in avian embryos, and genetic lineage tracing in mice, we investigated the spa
Externí odkaz:
https://doaj.org/article/91a9da3c78ca4d5aac16920103726488
Autor:
Khawla Belhoul, Mei Sheng Duh, Vicky Huang, Raffaella Origa, John B. Porter, Silverio Perrotta, Alexandra Kouraklis, Jackie Han, Ali T. Taher, Andreas Bruederle, Priyanka Bobbili
Publikováno v:
American Journal of Hematology
Autor:
Qingqing Zhu, Lu Song, Guangdun Peng, Na Sun, Jun Chen, Ting Zhang, Nengyin Sheng, Wei Tang, Cheng Qian, Yunbo Qiao, Ke Tang, Jing-Dong Jackie Han, Jinsong Li, Naihe Jing
Publikováno v:
eLife, Vol 3 (2014)
The neural fate commitment of pluripotent stem cells requires the repression of extrinsic inhibitory signals and the activation of intrinsic positive transcription factors. However, how these two events are integrated to ensure appropriate neural con
Externí odkaz:
https://doaj.org/article/41b05fe34676495fa3fa0b7a33ff13ac
Autor:
Franco Locatelli, Tommaso Stefanelli, Valkal Bhatt, Shashikant Apte, Nada Hamad, Stephanie J. Lee, Francesca Bonifazi, Takanori Teshima, Jackie Han, Kentaro Fukushima, Maanasa Gowda, Ivan S. Moiseev, Juan Carlos Vallejo Llamas, Joseph Pidala, Francis Ayuk, Robert Zeiser, Tsila Zuckerman, Mike Zuurman
Publikováno v:
Blood. 138:3909-3909
BACKGROUND Approximately 50% of patients (pts) who receive initial cGVHD therapy are steroid refractory or dependent (SR/D); standard second-line therapy has yet to be established. Quality of life (QOL) in these pts is poor and worsens with disease s